Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I like the diversity of topics that MedCity News covers – ranging from devices to policy to start-up companies. Always something interesting to find.”

Robert J. Szczerba, Ph.D., CEO, X Tech Ventures


Sign up for our daily newsletter


Minimally invasive weight loss device maker quietly raises $2.75 million

4:47 pm by | 0 Comments

Although it’s trying to keep quiet about its product, a medical device startup developing a new treatment for obesity revealed this week it’s in the middle of raising $5.5 million.

According to a recently filed U.S. Securities and Exchange Commission document, Vibrynt Inc. has raised half of a $5.5 million offering from five investors.

Vibrynt’s website provides little information about the device and says only that the company is “dedicated to creating minimally invasive therapies for patients suffering from morbid obesity.” A phone call to CEO Beverly Hess was not immediately returned.

Advertisement

Vibrynt’s is another addition to the list of minimally or noninvasive weight loss devices being developed, tested or awaiting U.S. Food and Drug Administration approval, including EndoSphere’s Satisphere, EnteroMedics’ Maestro system, GI Dynamics’ EndoBarrier and BAROnova’s TransPyloric Shuttle system.

The good news is the $1.2 billion obesity treatment market is growing, although it’s expected to become more segmented. The bad news? It’s hard to get weight loss devices to market in the U.S. The FDA has cleared only three medical devices for the treatment of obesity in the last 25 years, and earlier this month, an FDA advisory panel asserted that riskier devices should result in more weight loss than lower-risk methods.

Spun out of the California medical device incubator ExploraMed in 2007, Vibrynt has already done at least three previous rounds of financing, according to SEC documents. Investors include Delphi Ventures, New Enterprise Associates and Texas Pacific Group.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author

0 comments